| Dr Jeffrey Edward Mcwilliams, MD | |
|
3433 Chelan Dr, West Linn, OR 97068-9290 | |
| (503) 723-8321 | |
| Not Available |
| Full Name | Dr Jeffrey Edward Mcwilliams |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 3433 Chelan Dr, West Linn, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114920899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD16561 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Edward Mcwilliams, MD 3433 Chelan Dr, West Linn, OR 97068-9290 Ph: (503) 723-8321 | Dr Jeffrey Edward Mcwilliams, MD 3433 Chelan Dr, West Linn, OR 97068-9290 Ph: (503) 723-8321 |
News Archive
At its annual meeting today with the investment community, Eli Lilly and Company highlighted how its innovation-based strategy will enable it to better serve patients and compete effectively in a challenging health care environment. The company also detailed the progress being made in its labs and across its five new business units on an expanding pipeline of innovative molecules and marketed medicines, and provided investors with the company's financial guidance for 2010.
Cancer Research UK scientists found that more boys than girls, aged 4 to 16, liked fatty and sugary foods, meat, processed meat and eggs while more girls than boys liked fruit and vegetables which can help to reduce cancer risk in later life.
VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System.
The International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today announced plans to sign a cooperative agreement with the Chinese Health Promotion Foundation (CHPF), an agency that operates under the Chinese Ministry of Health, to promote awareness of myeloma in China and to encourage measures to prevent and combat the disease.
University of Illinois researchers Soo-Yeun Lee and Shelly Schmidt are trying to solve a mystery: Why doesn't diet soda taste more like regular soda? Can a well-trained panel of "taste testers" pinpoint the exact problem? And can food scientists do anything to fix it?
› Verified 2 days ago
Colin M Mcdonough, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1899 Blankenship Rd, West Linn, OR 97068 Phone: 503-513-3350 | |
Dr. Huey J Meeker, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18676 Willamette Dr, Suite 100, West Linn, OR 97068 Phone: 503-635-6430 Fax: 503-635-1342 | |
Jennifer W Miller-davis, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22400 Salamo Rd, Suite 201, West Linn, OR 97068 Phone: 503-723-7234 Fax: 503-650-4464 | |
Dr. Eliza Oh, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1800 Blankenship Rd, Ste 475, West Linn, OR 97068 Phone: 503-344-6065 Fax: 503-344-6065 | |
Cristina Therese De Castro-dela Cruz, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1899 Blankenship Rd, West Linn, OR 97068 Phone: 503-513-3350 | |
Robert V. Eller, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1899 Blankenship Rd, West Linn, OR 97068 Phone: 503-513-3350 |